Save
Case Report Pathology
ESGO eAcademy, Gwendoline Side-Pfennig, 99298
HCG in Gestational Trophoblastic Disease
ESGO eAcademy, Teun van Herwaarden, 99295
Case: Clinical Consequences of Different hCG Assays
ESGO eAcademy, Yalck Eysbouts, 99294
History of Gestational Trophoblastic Disease
ESGO eAcademy, Rene H.M. Verheijen, 99293
Immunotherapy Represents the Future for Ovarian Cancer
ESGO eAcademy, Bradley Monk, 96876
Immunotherapy Has Never Worked and Will Never Work in Ovarian Cancer
ESGO eAcademy, Eric Pujade-Lauraine, 96875
How To Negotiate Support with Pharma Companies for Sponsored Trials
ESGO eAcademy, Andreas Du Bois, 96873
How To Write a Grant for Academic Trials (Investigator-Initiated)
ESGO eAcademy, Sandro Pignata, 96872
The Hurdles of Conducting Trials across Different Countries: Focus on EU Regulations and Differences Which May Constitute Barriers to Run an ENGOT Trial
ESGO eAcademy, Jacobus Pfisterer, 96871
The Challenge of Initiating a National Cooperative Trial Group: Tricks and Tips
ESGO eAcademy, Mansoor Raza Mirza, 96870
Outside EU Regulations: Activating a Study in Switzerland
ESGO eAcademy, Cristiana Sessa, 96983
Managing Depression in Cancer Patients
ESGO eAcademy, Madeline Li & Gary Rodin, 63587
Reversing Mutated p53 to Wild Type
ESGO eAcademy, Sevilay Altintas, 63068
Inhibiting the Gain-of-Function of Mutated p53
ESGO eAcademy, Nicole Concin, 63067
Why Signatures Miss the Goal in Ovarian Cancer
ESGO eAcademy, MICHAEL BIRRER, 63066
Why Signatures Are the Best Way to Identify Subgroups in Ovarian Cancer
ESGO eAcademy, Charlie Gourley, 63065
The Tricky Decision to Allow Cross-Over or Not in a Trial
ESGO eAcademy, Bradley J. Monk, 63064
Funding Options, Legal Aspect and Insurance Hurdles, How To Select Centers for Surgical Trials?
ESGO eAcademy, Jacobus Pfisterer, 63060
What Are the Endpoints and Do We Have the Right Questionnaires for QOL? What Are the Open Questions in Relapse Ovarian Cancer?
ESGO eAcademy, Philipp Harter, 63061
Anaesthetic complications
ESGO eAcademy, Oliver Groll, 63116
Injury of the gastrointestinal tract
ESGO eAcademy, Gökhan Yagci, 63094
Robotic debulking surgery
ESGO eAcademy, Javier Magrina, 63093
EU reimbursement update and the role of medical expertise in Driving Dr.G change
ESGO eAcademy, Susanne Habetha, 63134
Chance of cost reduction and increase of efficiency in robotic surgery
ESGO eAcademy, Petur Reynisson, 63133
Cost analysis in endometrial cancer patients
ESGO eAcademy, Frederic Goffin, 63132
Cost evaluation (French analysis)
ESGO eAcademy, Eric Lambaudie, 63131
How to implement a registry?
ESGO eAcademy, Eric Lambaudie, 63092
The 'Art of Docking': Key for successful robotic surgery
ESGO eAcademy, Henrik Falconer, 63130
Robotic skills assessment: to score or not score ?
ESGO eAcademy, Henk W.R. Schreuder, 63088
Compartment visualization in embryologically defined surgery
ESGO eAcademy, Martin Heubner, 63129
Education in robotics: The U.S. experience
ESGO eAcademy, Gokhan S. Kilic, 63089
Applicability and feasibility of laparoscopic surgery of uterine cancer in patients with BMI under 30. Evaluation of a policy in favor of minimal invasive surgery in a single center
ESGO eAcademy, Denis Querleu, 63126
Perioperative morbidity and outcome analysis of robotically assisted laparoscopic radical hysterectomy
ESGO eAcademy, Fabrice Narducci, 63125
Robotic surgery and technique of radical hysterectomy in cervical and endometrial cancer
ESGO eAcademy, Angelo Maggioni, 63124
Evidence for adequate quality in radical hysterectomy by endoscopy
ESGO eAcademy, Roberto Tozzi, 63123
Robotic Surgery – less morbidity maintaining efficacy?
ESGO eAcademy, Loic Boulanger, 63143
Present and future development of robotic surgery in gynecology: Visions, expectations and demands
ESGO eAcademy, Ignace Vergote, 63083
SPECT/CT & sentinel node – an alternative to lymphadenectomy
ESGO eAcademy, Ronald P. Zweemer, 63121
Adhesion prevention in robotic myomectomy
ESGO eAcademy, Jasper Verguts, 63151
The need for guidelines and standards in robotic surgery
ESGO eAcademy, Dezita Taylor, 63157
New robotic systems
ESGO eAcademy, Rene H.M. Verheijen, 63138
Innovations of robotically assisted laparoscopy – Single port surgery
ESGO eAcademy, Fatih Sendag, 63136
RoundTable (Questions&Answers) of State of the Art Conference
ESGO eAcademy, Session Speakers, 62459
Patient´s expectations and perspectives about cancer care in ovarian cancer
ESGO eAcademy, Elena Ioana Braicu, 62458
Follow up of advanced stage invasive ovarian cancers
ESGO eAcademy, Gordon J.S. Rustin, 62457
Follow up of early stage invasive ovarian cancer, fertility sparing treatment
ESGO eAcademy, Rene H.M. Verheijen, 62456
Non epithelial ovarian tumours
ESGO eAcademy, Nicoletta Colombo, 62455
Borderline ovarian tumor follow up
ESGO eAcademy, Philippe Morice, 62454
Familial risk and its management
ESGO eAcademy, Usha Menon, 62453
Imaging strategies for follow up
ESGO eAcademy, Nandita de SOUZA, 62451
Imaging strategies for follow up
ESGO eAcademy, Manuela LUDOVISI, 62452
The Role of the Pathologist in Planning Follow up
ESGO eAcademy, Silvestro CARINELLI, 62450
The Role of Biomarkers in the Follow up in Ovarian Cancer
ESGO eAcademy, Massimo GION, 62449
Take home message of State of the Art Conference
ESGO eAcademy, K. Rainer Kimmig, 62446
RoundTable (Questions&Answers) of State of the Art Conference
ESGO eAcademy, Panel, 62444
Follow up of special histotypes including sarcomas
ESGO eAcademy, Nicholas Reed, 62443
Follow up after the treatment of endometrial cancer
ESGO eAcademy, ENRICO SARTORI, 62442
Endometrial cancer: Familial risk and its management
ESGO eAcademy, Usha Menon, 62441
Imaging strategies in the follow-up of endometrial cancer
ESGO eAcademy, Nandita de SOUZA, 62439
Imaging strategies for follow up
ESGO eAcademy, Manuela LUDOVISI, 62440
The Role of the Pathologist in Planning Follow up
ESGO eAcademy, Sigurd Lax, 62438
Take home message of State of the Art Conference
ESGO eAcademy, Tiziano Maggino, 62434
Take home message of State of the Art Conference
ESGO eAcademy, David Cibula, 62435
RoundTable (Questions&Answers)of State of the Art Conference
ESGO eAcademy, Session Speakers, 62433
Follow up after integrated therapy
ESGO eAcademy, Nicholas Reed, 62432
Follow up after surgical treatment
ESGO eAcademy, Tiziano Maggino, 62431
Imaging strategies for follow up
ESGO eAcademy, Nandita de SOUZA, 62429
Imaging Strategies for follow up
ESGO eAcademy, Manuela LUDOVISI, 62920
The Role of the Pathologist in Planning Follow up in Endometrial Cancer
ESGO eAcademy, Sigurd Lax, 62428
The Obstetrics Management after fertility sparing Treatment
ESGO eAcademy, Tullia TODROS, 62427
Follow up after Fertility Sparing Treatment
ESGO eAcademy, Fabio Landoni, 62426
Follow up after the treatment of cervical pre-cancer and microinvasive cancer
ESGO eAcademy, Vesna Kesic, 62425
The cost of follow up: looking for efficacy and effectiveness
ESGO eAcademy, Giovannino CICCONE, 62419
The psychological impact of the follow up procedures
ESGO eAcademy, Eva Greimel, 62418
Risk of secondary cancer after treatment of gynaecological cancer
ESGO eAcademy, David Cibula, 62417
The role of the imaging (CT-RMI-PET/CT) in the follow up
ESGO eAcademy, Nandita de SOUZA, 62416
The role of ultrasound procedures in the follow up
ESGO eAcademy, Manuela LUDOVISI, 62415
Follow up in Gynaecological Malignancies : a challenge
ESGO eAcademy, Paolo Zola, 62414
Beyond the medical aspect: the point of view of the patient
ESGO eAcademy, Paola MOSCONI, 62413
Sexuality and Cancer
ESGO eAcademy, Woet Gianotten & Annette Hasenburg, 58162
Managing Suicide Risk in Cancer Patients
ESGO eAcademy, Maggie Watson & Luigi Grassi, 58153
Classical laparoscopical surgery for hysterectomy, indication and outcome
ESGO eAcademy, Andreas Müller, 63140
Drugable Targets in Ovarian Cancer
ESGO eAcademy, MICHAEL BIRRER, 55524
Early Trials for Targeted Therapy: Specificity and Pitfalls
ESGO eAcademy, Cristiana Sessa, 55523
Panel Discussion
ESGO eAcademy, Session Speakers, 56036
Endpoints in Clinical Trials
ESGO eAcademy, Nicoletta Colombo, 55522
Improvement in Treatment for Ovarian Cancer: a 40 Year Journey
ESGO eAcademy, Stan Kaye, 55520
Critical Review of Clinical Trials - What We Learn from Negative Trials and Where Are We Going?
ESGO eAcademy, Christian Marth, 55519
Panel Discussion
ESGO eAcademy, Session Speakers, 56035
Elderly: the US Perspective
ESGO eAcademy, Bradley J. Monk, 55518
Endpoints and Trial Design in Geriatric Oncology
ESGO eAcademy, Sandro Pignata, 55517
Specificity of Elderly and Chemotherapy
ESGO eAcademy, Gilles Freyer, 55516
How To Calculate Costs of Clinical Trials
ESGO eAcademy, Jacobus Pfisterer, 55515
How To Incorporate Translational Research in Trials - Lessons from Anti-Angiogenic Trials
ESGO eAcademy, MICHAEL BIRRER, 55514
Regulatory Awareness Programme - Regulated Markets
ESGO eAcademy, Andrea Laslop, 65036
Clinical Trial Phases
ESGO eAcademy, Regina Berger, 57604
What is a clinical trial?
ESGO eAcademy, Regina Berger, 57603
Inguinal Lymphadenectomy: Reducing Dehiscence Rate
ESGO eAcademy, Ignacio Zapardiel, 95018
Single Port Extraperitoneal Paraaortic Lymphadenectomy
ESGO eAcademy, Ignacio Zapardiel, 95019
Video Endoscopic Inguinofemoral Lymphadenectomy in Vulvar Cancer
ESGO eAcademy, Alvaro Zapico, 95020

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings